Results 51 to 60 of about 8,454 (202)

A Rare Case Report of Neuroimaging, Electrophysiological, and Dynamic Laryngoscopy Studies in a Stroke Patient of Foix‐Chavany‐Marie Syndrome

open access: yesClinical Case Reports, Volume 14, Issue 4, April 2026.
ABSTRACT Foix‐Chavany‐Marie Syndrome (FCMS), also known as opercular syndrome, is a rare neurological disorder caused by an ischemic stroke that results in autonomic‐voluntary dissociation. In this case report, we describe a patient who presented with an acute right frontal and parietal cortical lesion, in addition to a remote infarction in the left ...
Lu Xia   +7 more
wiley   +1 more source

Rational Selection Of Proton Pump Inhibitors (Ppis) Through An Objective Scoring System For Effective Formulary Management [PDF]

open access: yes, 2011
Pemilihan ubat secara rasional adalah penting dalam pengurusan formulari yang berkesan.
Lim, Lynette, Chu Ann
core   +1 more source

The Pharmacogenetics of Cytochrome P450 2C19 Enzymes - Effects on Clopidogrel and Proton Pump Inhibitors [PDF]

open access: yes, 2014
BACKGROUND: Cytochrome P450 (CYP) enzymes play important roles in human, including drug metabolism. CYP2 is the largest family of human CYP, with its sequence comprising almost one third of all CYP sequences, and responsible for the metabolism of ...
Muliaty, D. (Dewi)   +1 more
core   +4 more sources

Differentiation therapy for non-acidic gastroesophageal reflux disease [PDF]

open access: yesТерапевтический архив, 2017
Aim. To investigate the clinical and pathogenetic features of the non-acidic types of gastroesophageal reflux disease (GERD) and to evaluate the impact of combined therapy versus monotherapy on the course of this disease. Subjects and methods.
N B Lishchuk   +2 more
doaj   +1 more source

Visibility Evaluation of Fundic Gland Polyp Associated With Proton Pump Inhibitor in Texture and Color Enhancement Imaging

open access: yesDEN Open, Volume 6, Issue 1, April 2026.
ABSTRACT Objectives A ‘gray color sign’ (GCS) is a new endoscopic feature of fundic gland polyp associated with proton pump inhibitor (PPI‐FGP). Here, we compare the ability of texture and color enhancement imaging (TXI) to white light imaging (WLI) with regard to the detection of GCS. Methods In this prospective study, 19 consecutive patients with PPI‐
Ryota Uchida   +17 more
wiley   +1 more source

Tegoprazan in Gastroesophageal Reflux Disease and Related Acid‐Mediated Conditions: A Systematic Review and Meta‐Analysis

open access: yesJGH Open, Volume 10, Issue 4, April 2026.
ABSTRACT Gastroesophageal reflux disease (GERD) is a chronic relapsing disorder often inadequately controlled with proton pump inhibitors (PPIs), particularly in patients with nocturnal acid breakthrough (NAB) or non‐erosive reflux disease (NERD). Tegoprazan, a potassium‐competitive acid blocker (PCAB), offers rapid, potent, and CYP2C19‐independent ...
Sanjay Bandyopadhyay   +4 more
wiley   +1 more source

Prescription Behaviour and Drug Interactions of Acid Suppressants With Tyrosine Kinase Inhibitors in Patients With Leukaemia: Data From Germany

open access: yeseJHaem, Volume 7, Issue 2, April 2026.
ABSTRACT Background Tyrosine kinase inhibitors (TKIs) are essential in treating chronic myeloid leukaemia (CML) and other malignancies. Their absorption, however, is highly pH‐dependent, making them susceptible to interactions with acid‐suppressing agents such as proton pump inhibitors (PPIs), histamine‐2 receptor antagonists (H2RAs) and antacids ...
Marek Lapka   +5 more
wiley   +1 more source

Is the long-term use of proton pump inhibitors safe? [PDF]

open access: yes, 2004
Long-term use of proton pump inhibitors (PPIs) appears safe, resulting in no clinically relevant adverse effects (strength of recommendation: B, based on nonsystematic reviews, cohort studies, or low-quality randomized controlled trials).
Malaty, Wail   +2 more
core  

Vonoprazan prevents low-dose aspirin-associated ulcer recurrence: randomised phase 3 study [PDF]

open access: yes, 2017
journal ...
Ashida, Kiyoshi   +7 more
core   +2 more sources

Home - About - Disclaimer - Privacy